Vaxcyte Launches $1 Billion Offerings of Stock, Prefunded Warrants, 2032 Notes

MT newswire2026/10/05 21:07

05:07 PM EDT, 10/05/2026 (MT Newswires) -- Vaxcyte (PCVX) launched underwritten offerings of $500 million of its common stock and prefunded warrants and $500 million of convertible senior notes due 2032, the company said Monday. The company intends to grant underwriters 30-day overallotment options to buy up to an additional $75 million of common stock and $75 million of notes. Net proceeds will be used to fund clinical development of Vaxcyte's pneumococcal vaccine programs, including VAX-31, manufacturing expansion, research and development, and general corporate purposes, the company said. Vaxcyte shares fell 3.4% in after-hours trading.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

The value of cryptocurrency assets held by the U.S. government has shrunk by $16 billion from last year’s peak.

AiCoin•2026/10/11 03:23

Copper prices approach historic highs! UBS remains bullish: "Still most optimistic"

华尔街见闻•2026/10/11 01:57

A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year

BeInCrypto•2026/10/10 22:48

The number of stablecoin holders on the Solana chain has surpassed 14 million.

AiCoin•2026/10/10 21:35